Alterations of membrane properties in erythrocytes of salt hypertensive Sabra rats.
This study was designed to investigate the effects of a hypertensive stimulus, high salt intake, in hypertension-prone (SBH) and -resistant (SBN) Sabra rats on erythrocyte Na+ content (Na+i), Ca2+ influx and cytosolic Ca2+ concentration ([Ca2+]i). The relationships of these parameters to plasma lipids, circulating digoxin-like immunoreactivity and membrane microviscosity, determined by the fluorescence anisotropy of trimethylamino-diphenylhexatriene (TMA-DPH) and diphenylhexatriene (DPH), were also evaluated. Erythrocytes of SBH rats were characterized by increased [Ca2+]i, unchanged Ca2+ influx and reduced Na+i. There were no significant differences in the plasma digoxin-like immunoreactivity between the two strains. High-salt intake decreased membrane microviscosity (DPH anisotropy) in SBH rats but did not alter the above parameters. Erythrocyte [Ca2+]i correlated positively with diastolic blood pressure and negatively with erythrocyte Na+i. Membrane dynamics evaluated by the two fluorescent probes did not correlate with [Ca2+]i, Ca2+ influx or Na+i whereas DPH anisotropy was inversely related to blood pressure. These relationships were independent of plasma cholesterol or triglycerides. It can be concluded that 1) similarly to earlier observations in essential hypertension and spontaneously hypertensive rats, erythrocyte [Ca2+]i correlates positively with blood pressure in salt-dependent hypertension, and 2) increased erythrocyte Na+ content need not be a hallmark of hypertension.
Pernollet
M G
MG
Necker Medical School, CNRS URA 1482, Paris, France.
David-Dufilho
M
M
Zicha
J
J
Kunes
J
J
Devynck
M A
MA
D000818:Animals; D001794:Blood Pressure; D001798:Blood Proteins / Q000032:analysis; D002118:Calcium / Q000097:blood*; D002298:Cardenolides; D003600:Cytosol / Q000378:metabolism; D004077:Digoxin; D004198:Disease Susceptibility; D004910:Erythrocyte Membrane / Q000187:drug effects*; D005454:Fluorescence Polarization; D006321:Heart / Q000187:drug effects; D006973:Hypertension / Q000097:blood* / Q000503:physiopathology; D008055:Lipids / Q000097:blood; D008297:Male; D009929:Organ Size; D051381:Rats; D012503:Saponins; D012964:Sodium / Q000097:blood*; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage*; D014783:Viscosity
D001798:Blood Proteins; D002298:Cardenolides; D008055:Lipids; D012503:Saponins; D017673:Sodium Chloride, Dietary; C034504:digoxin-like factors; D004077:Digoxin; D012964:Sodium; D002118:Calcium